Literature DB >> 828261

The metabolism of gemfibrozil.

R A Okerholm, F J Keeley, F E Peterson, A J Glazko.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 828261      PMCID: PMC1864041     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  3 in total

1.  BIOCHEMICAL ASPECTS OF TOXICOLOGY OF ATROMID.

Authors:  J M THORP
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

2.  Absorption and disposition of 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid, WIN 35,833, in rats, monkeys, and men.

Authors:  C Davison; D Benziger; A Fritz; J Edelson
Journal:  Drug Metab Dispos       Date:  1975 Nov-Dec       Impact factor: 3.922

3.  Metabolism of a new hypolipidemic agent, 2-acetamidoethyl(p-chlorophenyl) (m-trifluoromethylphenoxy)-acetate (halofenate) in the rat, dog, rhesus monkey and man.

Authors:  H B Hucker; L T Grady; B M Michniewicz; S C Stauffer; S E White; G E Maha; F G McMahon
Journal:  J Pharmacol Exp Ther       Date:  1971-11       Impact factor: 4.030

  3 in total
  6 in total

1.  Gemfibrozil absorption and elimination in kidney and liver disease.

Authors:  H Knauf; E U Kölle; E Mutschler
Journal:  Klin Wochenschr       Date:  1990-07-05

Review 2.  Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.

Authors:  P A Todd; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

3.  Interconversion pharmacokinetics of simvastatin and its hydroxy acid in dogs: effects of gemfibrozil.

Authors:  Thomayant Prueksaritanont; Yue Qiu; Lillian Mu; Kimberly Michel; Janice Brunner; Karen M Richards; Jiunn H Lin
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

4.  Compliance with medication in the Helsinki Heart Study.

Authors:  H Mäenpää; V Manninen; O P Heinonen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Myotoxicity of gemfibrozil in cynomolgus monkey model and its relationship to pharmacokinetic properties.

Authors:  Aiming Liu; Shuilin Xie; He Sun; Frank J Gonzalez; Xiaoxiong Wei; Renke Dai
Journal:  Toxicol Appl Pharmacol       Date:  2008-12-25       Impact factor: 4.219

6.  Structural Analysis of Human Serum Albumin in Complex with the Fibrate Drug Gemfibrozil.

Authors:  Stefano Liberi; Sara Linciano; Giulia Moro; Luca De Toni; Laura Cendron; Alessandro Angelini
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.